Search filters

List of works by Stephen A. Strickland

A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia

scientific article published on 30 May 2020

Acute myeloid leukemia, version 2.2013.

scientific article

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.

scientific article published on 4 June 2012

Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission

scientific article published on July 2015

Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia

scientific article

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.

scientific article published on 10 January 2014

Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia

scientific article

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

scientific article published on 06 January 2021

Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach

scientific article

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

scientific article

Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia

scholarly article by Farhad Ravandi et al published November 2018 in Haematologica

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.

scientific article

REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia

scientific article

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study

scientific article

The microculture-kinetic (MiCK) assay: the role of a drug-induced apoptosis assay in drug development and clinical care

scientific article

Updated safety of midostaurin plus chemotherapy in newly diagnosed FLT3 mutation-positive acute myeloid leukemia: the RADIUS-X expanded access program

scientific article published on 19 August 2020

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

scientific article published on 30 July 2015

Paulina is supported by:

About Paulina

Help